SIB LLC’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$275K Sell
59,200
-800
-1% -$4.4K 0.15% 18
2024
Q3
$416K Hold
60,000
0.2% 18
2024
Q2
$468K Hold
60,000
0.25% 18
2024
Q1
$426K Hold
60,000
0.2% 18
2023
Q4
$402K Hold
60,000
0.21% 18
2023
Q3
$338K Hold
60,000
0.2% 18
2023
Q2
$331K Hold
60,000
0.19% 17
2023
Q1
$375K Hold
60,000
0.23% 17
2022
Q4
$280K Hold
60,000
0.2% 17
2022
Q3
$280K Hold
60,000
0.21% 18
2022
Q2
$355K Hold
60,000
0.27% 18
2022
Q1
$1.16M Hold
60,000
0.71% 16
2021
Q4
$1.96M Hold
60,000
1.02% 17
2021
Q3
$2.46M Hold
60,000
1.36% 18
2021
Q2
$2.16M Hold
60,000
1.21% 18
2021
Q1
$2.34M Hold
60,000
1.38% 17
2020
Q4
$2.42M Buy
+60,000
New +$2.76M 1.62% 17

Other funds holding GDRX

SIB LLC's GDRX Position: Q4 2024 in Review

SIB LLC reduced its GoodRx Holdings (GDRX) stake by 1.3% in Q4 2024, selling an estimated $4.4K and leaving 59,200 shares worth $275K. The position accounts for 0.15% of the portfolio, ranked #18.

SIB LLC first reported a position in GDRX in Q4 2020 and has held it in 17 quarters since. The position peaked at $2.46M in Q3 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • SIB LLC held 59,200 shares of GoodRx Holdings worth $275K as of Q4 2024.
  • SIB LLC sold 800 GoodRx Holdings shares in Q4 2024, an estimated $4.4K.
  • GoodRx Holdings made up 0.15% of SIB LLC's portfolio in Q4 2024, its #18 holding.
  • SIB LLC first reported a position in GoodRx Holdings in Q4 2020 and has held it in 17 quarters since.
  • SIB LLC's GoodRx Holdings position peaked at $2.46M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on SIB LLC's 13F filing for Q4 2024, filed 15 Jan 2025.